10:55 ASX time - TDX up 11.11% following this exposure (tip)in The Australian newspaper.
Biotech lovefest: Life Science Investment Summit
Tyrian Diagnostics (TDX, 1.8c) is also in the "selling shovels" category: its DiagnostiQ device, which analyses blood, sputum and other bodily secretions, is already being used for agricultural applications.
Finally, we haven't covered Tyrian Diagnostics before, but with $6m of cash and a $9m market cap, it's surely worth a spec buy punt.
CRITERION: Tim Boreham | October 28, 2009
http://www.theaustralian.news.com.au/business/story/0,,26268969-643,00.html
- Forums
- ASX - By Stock
- APL
- criterion: surely worth a spec buy punt
criterion: surely worth a spec buy punt
Featured News
Add APL (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
-0.035(25.9%) |
Mkt cap ! $5.649M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 10.0¢ | $8.401K | 84.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2659 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 48000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2659 | 0.100 |
1 | 10000 | 0.050 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 48000 | 1 |
0.140 | 20863 | 1 |
0.175 | 135000 | 2 |
0.200 | 10000 | 1 |
0.000 | 0 | 0 |
Last trade - 12.39pm 03/07/2024 (20 minute delay) ? |
Featured News
APL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online